Financial
How can people with chronic diseases get in contact with clinical trials?
How can people with chronic diseases get in contact with clinical trials?
How can people with chronic diseases get in contact with clinical trials that may help them? The invention of insulin a century ago revolutionized the treatment of diabetics worldwide. In recent years, the medical community has recognized that this chronic disease cannot be treated merely by managing blood sugar levels and that it is necessary to find new therapeutic solutions to help patients and their families manage the long struggle against the disease from which hundreds of thousands of Israelis are suffering.
Optio, a member of the Novolog Group, is trying to do just that. Optio helps patients with chronic diseases who desperately need new drugs and therapies by finding a suitable clinical trial for them using a dedicated platform that compiles information about clinical trials seeking
trial subjects.
“We use advanced digital tools and social networks to improve the recruitment process and connect patients to the trial groups that are suitable for them,” says Raphael Giami, Director of Business Development and Innovation at Trialog Clinical Trials Ltd. of the Novolog Group.
“This will enable investigators to expand their geographical reach and will provide patients with additional treatment options using innovative medicinal products that will reach the market only in about another decade.”
The digital screening system helps patients suffering from chronic and autoimmune diseases find the most appropriate clinical trials for them efficiently and free of charge and refers them to the relevant medical team.
Optio technology was developed to provide an innovative and effective strategy for making the most advanced treatments accessible by as many suitable patients as possible, thereby contributing to the advancement of medical research in Israel.
Optio Website - www.optio.co.il
.svg)